Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N1087 in Female Pattern Hair Loss
NCT07303322Phase 3Not yet recruiting
- Sponsor
- Eurofarma
- Start
- Jan 2027
- Primary completion
- Jul 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of N1087 in Female Pattern Hair Loss (FPHL), sponsored by Eurofarma. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
N1087
03
Conditions
Female Pattern Hair Loss (FPHL)
Beyond the preview
Go deeper on NCT07303322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07303322.